[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337656-105":59,"doc-detail-337656-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","transforming-post-pandemic-cancer-services","Transforming post pandemic cancer services","","COVID-19 disrupted cancer screening, symptomatic diagnosis, treatment pathways, and broader service activity in the UK, affecting patients, clinicians in primary and secondary care, and the health system. Restoring cancer services to pre-pandemic levels is unlikely to remove the harm, particularly given population ageing and rising cancer burden. Projected incidence may exceed 500,000 new cases per year by 2035. The article argues for strategic transformation using datasets and analytics to prioritise earlier diagnoses and mortality benefit, targeting underperforming groups to reduce inequity.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/transforming-post-pandemic-cancer-services/337656/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/transforming-post-pandemic-cancer-services/337656.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How did COVID-19 affect cancer screening programmes in the UK?","Question",{"text":113,"@type":114},"All three national cancer screening programmes were significantly impacted, with breast screening suffering the largest decline, including a reduction of more than 15% in the first pandemic year.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why is returning to pre-pandemic cancer service levels not enough?",{"text":118,"@type":114},"The paper states that restoration alone is unlikely to mitigate adverse impact, especially with an ageing population and increased cancer burden.",{"name":120,"@type":111,"acceptedAnswer":121},"What strategy does the paper propose for transforming post-pandemic cancer services?",{"text":122,"@type":114},"It calls for prioritising effort using available datasets and evidence, focusing on cancers where earlier diagnosis is feasible and clinically useful, with mortality benefit by preventing emergency presentations and using data/analytics and decision support.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337656,1790221926,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","British Journal of Cancer [www.nature.com/bjc](www.nature.com/bjc)  \nPERSPECTIVE OPEN   \nEpidemiology  \nTransforming post pandemic cancer services  \nThomas Round 1 ✉ , Lakshman Sethuraman2, Mark Ashworth1 and Arnie Purushotham3  \n© The Author(s) 2024  \n\n|  | This paper outlines the impact of the COVID-19 pandemic on cancer services in the UK including screening, symptomatic diagnosis, treatment pathways and projections on clinical outcomes as a result of these care disruptions. A restoration of cancer services topre-pandemic levels is not likely to mitigate this adverse impact, particularly with an ageing population and increased cancer burden. New cancer cases are projected to rise to over 500,000 per year by 2035, with over 4 million people living with and beyond cancer. This paper calls for a strategic transformation to prioritise effort on the basis of available datasets and evidence—in particular, to prioritise cancers where an earlier diagnosis is feasible and clinically useful with a focus on mortality benefit by preventing emergency presentations by harnessing data and analytics. This could be delivered by a focus on underperforming groups/areas to try and reduce inequity, linking near real-time datasets with clinical decision support systems at the primary and secondary care levels, promoting the use of novel technologies to improve patient uptake of services, screening and diagnosis, and |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| finally, upskilling and cross-skilling healthcare workers to expand supply of diagnostic and screening services. |  |  |\n|  | British Journal of Cancer (2024) 130:1233–1238; [https://doi.org/10.1038/s41416-024-02596-9](https://doi.org/10.1038/s41416-024-02596-9) |  |\n|  |  |  |\n\nCANCER SERVICES AND THE PANDEMIC  \nCoronavirus disease 2019 (COVID-19) impacted on all aspects of cancer diagnosis and care, including screening, diagnostic and treatment pathways. In this article we consider the evidence of impact on patients, healthcare professionals across primary and secondary care and the wider healthcare system, with proposed potential opportunities for the transformation of services.  \nBy late 2021, more than 47,000 people were “missing” a cancer diagnosis in the UK [1], with an estimate for National Health Service (NHS) in England to work at 110% of previous capacity for 17 months to catch up on missing cancer diagnoses.  \nImpact on the health service  \nScreening. All three national cancer screening programmes were significantly impacted with breast cancer screening being worst hit [2] with a decline of over 15% in the first year of the pandemic. The observed reductions in screening performance may be explained by the temporary suspension of national screening programmes during the early stages of the pandemic in England, and the inability or unwillingness of invitees to partake in screening once the programmes had been restored. As such, increased capacity to deliver additional screening appointments is needed to work through the backlog of outstanding patients who are eligible to attend.  \nHealth service activity. Prior to the start of the pandemic, primary care urgent suspected cancer (USC) (or 2-week wait (2WW)) referrals increased to over 2 million per year [3], with a subsequent  \nincrease in cancer detection, decrease in emergency presentations (EPs) and improved patient outcomes [4] .  \nDuring the pandemic lockdowns, there were significant decreases in non-COVID health service activity, including presentation to emergency departments and primary care. GP consultations for potential cancer clinical features decreased by 24% between 2019 and 2020 [5], particularly in the 6–12 weeks following the first national lockdown. There were approximately 300,000 fewer USC referrals in 2020/21 compared to 2019/20 . Despite the drop in referrals the detection rate continued to improve to 54.8%(145,495 cancers) picked up following USC","cbCaip9VyAa07ffo","https://ap.wps.com/l/cbCaip9VyAa07ffo","pdf",460175,"English","# Transforming post pandemic cancer services\n## Epidemiology\n## Cancer services and the pandemic\n## Impact on the health service\n## Waiting times\n## Staff burnout","[{\"question\":\"How did COVID-19 affect cancer screening programmes in the UK?\",\"answer\":\"All three national cancer screening programmes were significantly impacted, with breast screening suffering the largest decline, including a reduction of more than 15% in the first pandemic year.\"},{\"question\":\"Why is returning to pre-pandemic cancer service levels not enough?\",\"answer\":\"The paper states that restoration alone is unlikely to mitigate adverse impact, especially with an ageing population and increased cancer burden.\"},{\"question\":\"What strategy does the paper propose for transforming post-pandemic cancer services?\",\"answer\":\"It calls for prioritising effort using available datasets and evidence, focusing on cancers where earlier diagnosis is feasible and clinically useful, with mortality benefit by preventing emergency presentations and using data/analytics and decision support.\"}]","Transforming post pandemic cancer services | PDF",1790020012,15]